Bioactivation and reactivity research advances – 2023 year in review
Authors:
- Shuai WangSWShuai Wang
- Upendra A. ArgikarUAUpendra A. Argikar
- Maria ChatzopoulouMaria Chatzopoulou
- Sungjoon ChoSCSungjoon Cho
- Rachel D. CrouchRCRachel D. Crouch
- Deepika DhawareDDDeepika Dhaware
- Carley J. S. HeckCHCarley J. S. Heck
- Kevin M. JohnsonKJKevin M. Johnson
- Amit S. KalgutkarAKAmit S. Kalgutkar
- Joyce LiuJLJoyce Liu
- Bin MaBMBin Ma
- 2 July 2024
- journal article
- review article
- Published by Taylor & Francis in Drug Metabolism Reviews
- Vol. 56 (3) , 247-284
Abstract
Advances in the field of bioactivation have significantly contributed to our understanding and prediction of drug-induced liver injury (DILI). It has been established that many adverse drug reactions, including DILI, are associated with the formation and reactivity of metabolites. Modern methods allow us to detect and characterize these reactive metabolites in earlier stages of drug development, which helps anticipate and circumvent the potential for DILI. Improved in silico models and experimental techniques that better reflect in vivo environments are enhancing predictive capabilities for DILI risk. Further, studies on the mechanisms of bioactivation, including enzyme interactions and the role of individual genetic differences, have provided valuable insights for drug optimizations. Cumulatively, this progress is continually refining our approaches to drug safety evaluation and personalized medicine.Shuai Wang and Cyrus Khojasteh, on behalf of the authors.Keywords
This publication has 89 references indexed in Scilit:
- 4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamide salts: Novel hydrosoluble prodrugs of antimitotics selectively bioactivated by the cytochrome P450 1A1 in breast cancer cellsBioorganic Chemistry, 2023
- Elucidation of the relationship between evodiamine-induced liver injury and CYP3A4-mediated metabolic activation by UPLC-MS/MS analysisAnalytical and Bioanalytical Chemistry, 2023
- Is there enough evidence to classify cycloalkyl amine substituents as structural alerts?Biochemical Pharmacology, 2020
- 4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamides as new antimitotic prodrugs activated by cytochrome P450 1A1 in breast cancer cellsBioorganic & Medicinal Chemistry, 2018
- Evodiamine and Its Role in Chronic Diseases2016
- Acyl glucuronides: the good, the bad and the uglyBiopharmaceutics & Drug Disposition, 2010
- Structural Alerts, Reactive Metabolites, and Protein Covalent Binding: How Reliable Are These Attributes as Predictors of Drug Toxicity?Chemistry & Biodiversity, 2009
- Reactive intermediates in the oxidation of hydralazine by HOCl: the major oxidant generated by neutrophilsChemico-Biological Interactions, 1993
- Hydralazine: A potent inhibitor of aldehyde oxidase activity in vitro and in vivoBiochemical Pharmacology, 1985
- Oxidative metabolism of hydralazine. Evidence for nitrogen centered radicals formationBiochemical and Biophysical Research Communications, 1982